OTCMKTS:RADLY Raia Drogasil (RADLY) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free RADLY Stock Alerts $4.34 0.00 (0.00%) (As of 06/7/2024 ET) Add Compare Share Share Today's Range$4.34▼$4.3450-Day Range$4.34▼$5.9152-Week Range$4.05▼$8.25Volume124 shsAverage Volume2,077 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendShort InterestStock AnalysisAnalyst ForecastsChartDividendShort Interest Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Raia Drogasil Stock (OTCMKTS:RADLY)Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.Read More RADLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RADLY Stock News HeadlinesJune 9 at 7:44 AM | americanbankingnews.comRaia Drogasil (OTCMKTS:RADLY) Shares Down 8.2% July 8, 2022 | finance.yahoo.comBrazil’s Battered Stocks Could Rebound, but Not Before the Presidential VoteMay 5, 2022 | uk.investing.comRaia Drogasil SA ADR (RADLY)See More Headlines Company Calendar Ex-Dividend for 6/10 Dividend4/18/2024Today6/09/2024Dividend Payable6/10/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:RADLY CUSIPN/A CIKN/A Webwww.rd.com.br Phone551137695678FaxN/AEmployees57,708Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Marcílio D'Amigo Pousada (Age 59)CEO & Member of Executive Board Mr. Antonio Carlos CoelhoVP of Finance & Administrative and Member of Executive BoardMr. Eugênio De ZagottisVP of Corporate Planning, IR, M&A and Member of Executive BoardMr. Marcello De ZagottisVP of Commercial & Marketing and Member of Executive BoardMr. Fernando Kozel VarelaVP of Digital Transformation & Member of Executive BoardMr. Renato Cepollina RaduanVP of Store, Multichannel & Expansion Operations and Member of Executive BoardMs. Maria Susana De SouzaVP of People, Culture & Sustainability and Member of Executive BoardMr. Bruno Wright PipponziVP of Health Business & Member of Executive BoardCelso Pissi FilhoAccountant & Technical ManagerFlavio FogacaDirector of IR, Corporate Affairs & StrategyMore ExecutivesKey CompetitorsAlibaba Health Information TechnologyOTC:ALBHFAllstar Health BrandsOTCMKTS:ALSTClicks GroupOTCMKTS:CLCGYDocMorrisOTCMKTS:ZRSEFFire & FlowerOTCMKTS:FFLWFView All Competitors RADLY Stock Analysis - Frequently Asked Questions Should I buy or sell Raia Drogasil stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Raia Drogasil in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" RADLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RADLY, but not buy additional shares or sell existing shares. View RADLY analyst ratings or view top-rated stocks. How have RADLY shares performed in 2024? Raia Drogasil's stock was trading at $7.20 at the start of the year. Since then, RADLY shares have decreased by 39.7% and is now trading at $4.34. View the best growth stocks for 2024 here. How often does Raia Drogasil pay dividends? What is the dividend yield for Raia Drogasil? Raia Drogasil announced a dividend on Friday, December 22nd. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.0088 per share on Monday, January 8th. The ex-dividend date is Friday, December 29th. This is a positive change from the stock's previous dividend of $0.01. Read our dividend analysis for RADLY. When did Raia Drogasil's stock split? Raia Drogasil shares split before market open on Monday, May 22nd 2023. The 26-25 split was announced on Monday, May 22nd 2023. The newly issued shares were distributed to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split. How do I buy shares of Raia Drogasil? Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RADLY) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored📈 Alert: Gold Reaches New All Time High Amidst Inflation DataCentral Banks Have bought More Gold in the last 2 years than in all of history combined. That's right, the SAM...All American Assets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Raia Drogasil S.A. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Raia Drogasil With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.